Skip to content

The new boss of Boehringer Ingelheim

  • News

Ingelheim, July 4, 2025 – Since January 2025, Dr. Markus Wagner has been at the helm of Boehringer Ingelheim, one of the largest family-owned pharmaceutical companies worldwide. The 52-year-old biochemist, who previously served as Chief Scientific Officer at Novartis, has quickly established himself as a visionary yet pragmatic leader. But how does the new CEO tick, and what does his leadership mean for the future of the group? In an environment where the pharmaceutical industry is under pressure to innovate, Wagner is praised for his unconventional approach – and viewed critically. His plans are met with enthusiasm, but also with reservations, not least because of the political framework conditions in Germany. Wagner, born in Munich, brings an impressive resume. After studying biochemistry at LMU Munich and earning a doctorate in molecular biology, he held various leadership positions at Novartis, where he oversaw the development of several blockbuster drugs such as Entresto for heart failure… 

Merck completes multi-billion dollar pharma deal after research setbacks

  • News

Darmstadt, July 4, 2025 – German pharmaceutical and chemical company Merck KGaA has completed the largest pharmaceutical deal in almost two decades by acquiring the US biotech company SpringWorks Therapeutics for around 3 billion euros. The acquisition, completed on July 1, 2025, is expected to strengthen Merck's position in the lucrative market for cancer drugs. But the takeover raises questions: Is it a strategic move or a desperate attempt to close gaps in its own research? Critics see the deal as an admission that Merck's internal innovation power has stagnated in recent years. SpringWorks Therapeutics, a Stamford, Connecticut-based company, specializes in targeted cancer therapies, particularly for rare tumor diseases. With the acquisition, Merck is securing promising active ingredients such as Nirogacestat, a drug for the treatment of desmoid tumors, which has already received approval in the US. "This step accelerates the sustainable growth of our healthcare business," explained Merck… 

Parents fight to preserve Ludwig Hoffmann Elementary School in Friedrichshain

Berlin, July 4, 2025 – The school community of Ludwig Hoffmann Elementary School in Berlin-Friedrichshain faces an uncertain future: The Friedrichshain-Kreuzberg district office plans to relocate the traditional school from its listed building on Lasdehner Straße to a new building at the Sport and Recreation Center (SEZ). A petition on Change.org, online since June 20, 2025, calls for the preservation of the historic site and has already found broad support. Parents, teachers, and residents criticize the plans as undemocratic and a threat to the established community. Ludwig Hoffmann Elementary School, named after the renowned architect Ludwig Hoffmann, is more than just an educational institution. With around 460 students and a first-class reputation, particularly for its gifted education program, it is a central part of the Grünberger Kiez. The building, constructed between 1906 and 1908, is an architectural gem with an artfully designed facade, deeply rooted in Berlin's educational tradition. Parents describe… 

CMS finalizes 5.06% payment increase for Medicare Advantage and Part D changes for 2026

  • News

The Centers for Medicare & Medicaid Services (CMS) are increasing Medicare Advantage payments by 5.06% (over $25 billion) and continuing changes to the Part D program, including a $2,100 out-of-pocket maximum and a $35 maximum for insulin in 2026, per the Inflation Reduction Act. The Centers for Medicare & Medicaid Services (CMS) released the 2026 Medicare Advantage and Part D Rate Announcement on April 7, 2025, finalizing payment policies for the Medicare Advantage (MA) and Medicare Part D programs for calendar year (CY) 2026. Here are the key takeaways: These changes reflect CMS’s ongoing efforts to adapt Medicare programs to beneficiaries’ needs, reduce costs, and improve the quality of care while maintaining fiscal responsibility.

BioLab Holdings Launches Clinical Study on Amnion Grafts

Phoenix, July 3, 2025 – BioLab Holdings, Inc., a Phoenix-based manufacturer of medical devices for wound healing and regenerative therapies, has launched a multi-site clinical study to investigate the efficacy of its amnion-based products in treating chronic wounds. The study, titled “AMNIOHEAL RWE Trial,” focuses on hard-to-heal diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs). The investigation compares the effects of the Tri-Membrane Wrap™ and Membrane Wrap – Lite™ products against a retrospective control group that received standard of care (SOC) only. The goal is to generate real-world evidence (RWE) to improve healing outcomes for patients with chronic wounds. “This trial is a significant step in our mission to provide innovative, evidence-based solutions for wound care,” emphasized Dr. Marshall Medley, Chief Medical Officer at BioLab. The study includes patients whose wounds have persisted for at least four weeks and have not responded to SOC,… 

Elon Musk's America Party: A Threat to Trump's Republicans

  • News

On July 4, 2025, American Independence Day, Elon Musk plans to found the America Party, a new political force intended to challenge the established two-party system in the USA. This announcement comes amid an escalating conflict with President Donald Trump and could have far-reaching consequences for the political landscape of the United States. Musk, known as a technology visionary and one of the most influential entrepreneurs in the world, is leveraging his enormous wealth, his media platform X, and his polarizing public presence to launch a movement that could particularly put Trump and the Republican Party in a difficult position. This essay examines the reasons for Musk's plan, the strategic motives behind choosing July 4th as the founding date, and the potential dangers the America Party poses to Trump's political dominance. Why is Musk founding the America Party on July 4th? The founding of the America Party on July 4th… 

“One Big Beautiful Bill”: Trump's Debt Mountain Breaks Records – and Divides Musk and the Republicans

  • News

Washington, July 3, 2025 – The US Congress has opened a controversial chapter in American economic policy with the passage of the “One Big Beautiful Bill” (OBBB), as US President Donald Trump calls his mammoth tax and spending bill. The legislative package, over 900 pages long, which was pushed through the Senate on July 1, 2025, with a narrow majority and the decisive vote of Vice President J.D. Vance, promises tax cuts, massive investments in defense and border security, and cuts to social programs. However, the downside is a dramatic increase in US national debt, which has put even conservative Republicans and tech billionaire Elon Musk on alert. This analysis examines the contents of the bill, its fiscal impact, the political consequences, and the escalating feud between Trump and Musk. Contents of the “One Big Beautiful Bill”: A Bill with Far-Reaching Ambitions The “One Big Beautiful Bill” is a central initiative of Trump's second term, fulfilling his campaign promises… 

Analysis of the cumulative costs of migration policy in Germany from 2015 to 2025

Germany's migration policy, particularly since the so-called refugee crisis of 2015/2016, has significant financial implications for the federal government, the states, and the municipalities. This analysis examines the cumulative costs of migration policy from 2015 to 2025, based on available data, scientific studies, and official reports. It considers direct costs (e.g., for accommodation, care, integration) as well as indirect costs (e.g., social transfers, administration, addressing root causes of flight). The aim is to provide a well-founded and documented overview of the financial burdens incurred by migration policy, while also incorporating critical perspectives to appreciate the complexity of the topic. 1. Background: The Refugee Crisis and its Development In 2015, immigration to Germany reached a historic peak. According to the Federal Office for Migration and Refugees (BAMF), approximately 476,649 asylum applications were filed in 2015, and 745,545 in 2016. In total, around 1.5 million people seeking protection came to Germany in these years, primarily…

Turkey Vacation Cost Trap: High Bills Despite Health Insurance

Munich, July 3, 2025 – Turkey is a popular holiday destination, but for those with statutory health insurance, a doctor's visit can quickly become a cost trap. The European Health Insurance Card (EHIC), which covers emergency medical care within the EU, is not accepted in Turkey. Instead, travelers need a special holiday medical certificate (Form T/A 11), which must be applied for from the health insurance provider in advance. Without this certificate, high costs are threatened, as many vacationers are specifically directed to expensive hotel doctors or private clinics, warns ADAC. "If someone falls ill, the first point of contact for vacationers is usually the hotel doctor," explains Sascha Petzold, Head of Claims at ADAC Versicherung AG. Even with minor complaints like diarrhea, the bills are often inflated: while such treatment costs between 35 and 75 euros in Germany, private doctors in Turkey charge 280 to 380 euros – payable immediately. "This is extremely annoying, brings…

PrivacyWall.org and its significance for biomedicine

  • News

In an era where digital data collection is ubiquitous and the processing of sensitive health data plays a central role in biomedical research, data protection solutions like PrivacyWall.org are gaining increasing importance. The platform, operated by a group of Stanford graduates under the umbrella of Social Game Media Inc., positions itself as a pioneer in the fight against unwanted data collection and offers a search engine as well as privacy tools aimed at protecting user privacy. But what role does PrivacyWall.org play specifically in the context of biomedicine, where the protection of sensitive health data is crucial? This report sheds light on how the platform works, its relevance for biomedical research, and the challenges it faces. PrivacyWall.org: An Overview PrivacyWall.org is more than just a search engine. The platform combines anti-tracking technologies, ad-blocking features, and a unique function called "PrivateView," which allows users to visit websites anonymously without...